Proteomics‐Based Soluble Urokinase Plasminogen Activator Receptor Levels and Long‐Term Cardiovascular Outcomes in Survivors of Breast Cancer: A UK Biobank Study
In this cohort study of survivors of breast cancer, proteomics-based suPAR levels were associated with an increased risk for adverse cardiovascular outcomes, highlighting the potential role of suPAR as a shared risk factor for cancer and cardiovascular disease.
Authors
- Yan V. Sun (ORCID: https://orcid.org/0000-0002-2838-1824)
- ADITHYA K. YADALAM (ORCID: https://orcid.org/0000-0003-3610-4445)
- Anant Mandawat
- Salim S. Hayek (ORCID: https://orcid.org/0000-0003-0180-349X)
- Arshed Ali Quyyumi (ORCID: https://orcid.org/0000-0002-8166-679X)
- Chang Liu (ORCID: https://orcid.org/0000-0002-8918-7224)
Institutions
- Emory University (US)
- Cancer Institute (WIA) (IN)
- Atlanta VA Health Care System (US)
- The University of Texas Medical Branch at Galveston (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1161/jaha.124.039728
- Citations
- 1
- Primary Topic
- Protease and Inhibitor Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.94